The company plans to manufacture these tablets at its formulation manufacturing facility situated in the SEZ in Ahmedabad.

The EMPEROR-Preserved trial of empagliflozin (Jardiance; Boehringer Ingelheim/Eli Lilly) met its primary endpoint, according to top-line results released today, meaning a therapy with specific ...

A new analysis of the EMPEROR-Preserved trial sheds light on the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance; Boehringer Ingelheim/Eli Lilly) in patients ...

Empagliflozin reduces heart failure hospitalization risk in patients with acute myocardial infarction, irrespective of type 2 diabetes or chronic kidney disease status. The EMPACT-MI trial showed a 23 ...

Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Diabetes is a well-known risk factor for ...

Credit: Getty Images. The approval of empagliflozin for pediatric T2DM was based on data from the phase 3 DINAMO trial. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Its ...

Empagliflozin, compared with GLP-1RA, demonstrated improved cardiorenal outcomes among patients with type 2 diabetes. Empagliflozin vs cardioprotective glucagon-like peptide-1 receptor agonists ...

Empagliflozin improved clinical outcomes in patients with acute heart failure (AHF), regardless of blood pressure (BP) levels, with particularly strong benefits observed in those with diastolic BP ...

Please provide your email address to receive an email when new articles are posted on . The benefits of empagliflozin compared with placebo for HF with reduced ejection fraction occurred regardless of ...

The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of ...